Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B

K. Lim, Joseph; Yuan Chi Chang, Alex; Zaman, Atif; Martin, Paul; Fernández‐Rodríguez, Conrado; Korkmaz, Mete; Rossi, Simona; M. Ford, James; Noonan, Tamara; Cooney, Elizabeth; J. Navarro, Victor; Colombato, Luis

doi:10.14218/jcth.2020.00039

Public

Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B

Published in Journal of Clinical and Translational Hepatology • Oct 9, 2020

Authors:

Joseph K. Lim

Alex Yuan Chi Chang

Atif Zaman

Abstract

Background and Aims: In the REALM (Randomized, Observational Study of Entecavir to Assess Long-Term Outcomes Associated with Nucleoside/Nucleotide Monotherapy for Patients with Chronic HBV Infection) study, 12,378 patients with chronic hepatitis B virus (HBV) infection received up to 10 years of ran...

Subject

Medicine

Concordance

Entecavir

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!